Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Hormone Replacement Therapy
Fierce Healthcare
FDA rolls back warning labels on HRT products for menopause
Pharmas are expected to update and reprint product labeling to remove references to risks of cardiovascular disease, breast cancer and dementia.
Anastassia Gliadkovskaya
Nov 10, 2025 1:33pm
After 2 delays, FDA approves Ascendis' Yorvipath
Aug 12, 2024 11:10am
Ascendis must wait 3 more months for FDA verdict on TransCon PTH
May 14, 2024 5:36pm
Ascendis' hormone drug gets manufacturing-related CRL
May 1, 2023 2:32pm
Folx Health plans for the LGBTQ+ future by honoring its past
Jul 8, 2022 9:00am
Grants help transgender community be who they are
Apr 8, 2022 7:50am
